These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 6275782

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparative susceptibility of anaerobic bacteria to ticarcillin, cefoxitin, metronidazole, and related antimicrobial agents.
    Henderson DK, Chow AW, Guze LB.
    Antimicrob Agents Chemother; 1977 Apr; 11(4):679-82. PubMed ID: 856019
    [Abstract] [Full Text] [Related]

  • 5. Ceftizoxime and cefoxitin susceptibility testing against anaerobic bacteria: comparison of results from three NCCLS methods and quality control recommendations for the reference agar dilution procedure.
    Jones RN, Barry AL, Fuchs PC, Allen SD.
    Diagn Microbiol Infect Dis; 1987 Oct; 8(2):87-94. PubMed ID: 3480787
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Susceptibility of anaerobes to cefoxitin and other cephalosporins.
    Tally FP, Jacobus NV, Bartlett JG, Gorbach SL.
    Antimicrob Agents Chemother; 1975 Feb; 7(2):128-32. PubMed ID: 1137364
    [Abstract] [Full Text] [Related]

  • 10. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
    Mascellino MT, Prignano G, Iegri F, Lorenzi A.
    Boll Ist Sieroter Milan; 1982 Feb; 61(4):309-19. PubMed ID: 6100234
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin.
    Fu KP, Neu HC.
    Antimicrob Agents Chemother; 1980 Apr; 17(4):583-90. PubMed ID: 6967294
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL, Jacobus NV, Tally FP, Gorbach SL.
    Clin Ther; 1983 Apr; 5(6):603-16. PubMed ID: 6313195
    [Abstract] [Full Text] [Related]

  • 15. In-vitro activity of ceftizoxime against anaerobic bacteria and comparison with other cephalosporins.
    Chow AW, Finegold SM.
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():45-50. PubMed ID: 6296028
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antibacteroides and beta-lactamase inhibitory activities of moxalactam.
    Fu KP, Neu HC.
    J Antimicrob Chemother; 1981 Oct; 8(4):337-41. PubMed ID: 6271727
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.
    Rolfe RD, Finegold SM.
    Antimicrob Agents Chemother; 1981 Nov; 20(5):600-9. PubMed ID: 7325628
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.